+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Endoscopic screening and surveillance for Barrett's esophagus--clinical implications



Endoscopic screening and surveillance for Barrett's esophagus--clinical implications



Medgenmed 8(2): 66



There is now a clear causal relationship between symptomatic gastroesophageal reflux and esophageal adenocarcinoma (Lagergren et al, 1999). The risk factor is now identified as Barrett's metaplasia (Solaymani et al, 2004). Chronic reflux results in Barrett's metaplastic change, and the route to carcinoma is a stepwise progression, through dysplasia to invasive carcinoma (Jankowski et al, 2000). Earlier-stage disease is found in patients undergoing surveillance and is the major predictor of survival following surgery (Fountoulakis et al, 2004). Screening and surveillance by endoscopic biopsy regimen has profound implications for the allocation of healthcare resources and the provision of clinical services. Screening a high-risk group such as men with gastroesophageal reflux disease (GERD) will result in the detection of more patients with Barrett's esophagus, many of whom are asymptomatic. Once detected, questions remain as to surveillance intervals and the current methodology for surveillance. There are profound challenges with the accurate endoscopic and pathologic detection and categorization of Barrett's metaplasia, dysplasia , and, indeed, cancer. New endoscopic detection methods are being investigated to improve the diagnosis and definition of the premalignant phenotype. The detection of dysplasia requires increased surveillance and usually intervention either endoscopically or with surgery.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048953007

Download citation: RISBibTeXText

PMID: 16926805


Related references

Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review. Gastroenterology 137(6): 1869-1876, 2009

Endoscopic screening and surveillance for Barrett's esophagus: can claims data determine its effectiveness?. Gastrointestinal Endoscopy 57(7): 914-916, 2003

Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening. Medicine 94(39): E1105, 2016

Prevalence, clinical-endoscopic characteristics and predictive factors of Barrett's Esophagus in endoscopic screening for gastric cancer. Revista de Gastroenterologia del Peru 29(1): 24-32, 2009

Barrett's esophagus is frequently overdiagnosed in clinical practice: results of the Barrett's Esophagus Endoscopic Revision (BEER) study. Gastrointestinal Endoscopy 79(4): 565-573, 2014

M1106 Barrett's Esophagus is Over-Diagnosed in Clinical Practice: Pilot Results of the Barrett's Esophagus Endoscopic Reversal (Beer) Study. Gastroenterology 138(5): S-333, 2010

Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA 311(12): 1209-1217, 2014

Clinical and Endoscopic Predictors of Neoplastic Progression in Barrett's Esophagus Surveillance: A Multicenter Community Based Prospective Cohort Study. Gastroenterology 154(6): S-4, 2018

Tu1100 Endoscopic Surveillance for Barrett's Esophagus: A Population-Based Study of Surveillance Practice and Outcomes. Gastroenterology 142(5): S-746, 2012

Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. American Journal of Gastroenterology 93(6): 911-915, 1998

Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. Gastrointestinal Endoscopy 86(1): 1-17.E3, 2017

Development of Quality Indicators for Endoscopic Eradication Therapies (Eet) in Barrett's Esophagus: The Treat-Be (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. Gastrointestinal Endoscopy 83(5): Ab129-Ab130, 2016

Complications of gastroesophageal reflux disease. 2. Endoscopic diagnosis of Barrett esophagus--can Barrett esophagus be diagnosed by endoscopic observation alone?. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 89(1): 85-90, 2000

Endoscopic surveillance in Barrett's esophagus. Minerva Gastroenterologica E Dietologica 48(2): 63-71, 2006

Endoscopic surveillance of Barrett's esophagus. Does it help?. Journal of Thoracic and Cardiovascular Surgery 105(3): 383-7; Discussion 387-8, 1993